Cas:13456-78-5 n,n,n’,n’-tetrabenzyl-p-phenylenediamine manufacturer & supplier

We serve Chemical Name:n,n,n’,n’-tetrabenzyl-p-phenylenediamine CAS:13456-78-5 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

n,n,n',n'-tetrabenzyl-p-phenylenediamine

Chemical Name:n,n,n’,n’-tetrabenzyl-p-phenylenediamine
CAS.NO:13456-78-5
Synonyms:N,N,N’,N’-Tetrabenzyl-1,4-Benzenediamine;Tetra-N-benzyl-p-phenylendiamin;N,N,N’N’-tetrabenzyl-benzene-1,4-diamine;tetra-N-benzyl-p-phenylenediamine;N1,N1,N4,N4-Tetrabenzylbenzene-1,4-diamine
Molecular Formula:C34H32N2
Molecular Weight:468.63100
HS Code:2921590090

Physical and Chemical Properties:
Melting point:149-152ºC
Boiling point:650.5ºC at 760 mmHg
Density:1.147g/cm3
Index of Refraction:1.671
PSA:6.48000
Exact Mass:468.25700
LogP:8.10020

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like N,N,N’,N’-Tetrabenzyl-1,4-Benzenediamine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,N1,N1,N4,N4-Tetrabenzylbenzene-1,4-diamine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Tetra-N-benzyl-p-phenylendiamin Use and application,tetra-N-benzyl-p-phenylenediamine technical grade,usp/ep/jp grade.


Related News: A Phase 1/2 trial of the combination therapy has been fully enrolled, and the preliminary efficacy and safety data was presented at The American Society of Hematology (ASH) Annual Meeting in December 2018. n,n,n’,n’-tetrabenzyl-p-phenylenediamine manufacturer Chung also said South Korean citizens who had visited the province in the past 14 days should voluntarily quarantine themselves at home for two weeks after they arrive back into the country. n,n,n’,n’-tetrabenzyl-p-phenylenediamine supplier A Phase 1/2 trial of the combination therapy has been fully enrolled, and the preliminary efficacy and safety data was presented at The American Society of Hematology (ASH) Annual Meeting in December 2018. n,n,n’,n’-tetrabenzyl-p-phenylenediamine vendor A Phase 1/2 trial of the combination therapy has been fully enrolled, and the preliminary efficacy and safety data was presented at The American Society of Hematology (ASH) Annual Meeting in December 2018. n,n,n’,n’-tetrabenzyl-p-phenylenediamine factory The Department of Health and Human Services asked the Defense Department to provide several facilities capable of housing at least 250 people in individual rooms through to February 29, the Pentagon said.